testosterone propionate has been researched along with acetazolamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahmed, G; Elger, W; Meece, F; Nair, HB; Nickisch, K; Schneider, B; Wyrwa, R | 1 |
| Cheng, CP; Gerber, D; Lim, LT; Park, S | 1 |
3 other study(ies) available for testosterone propionate and acetazolamide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A prodrug design for improved oral absorption and reduced hepatic interaction.
Topics: Absorption, Physiological; Administration, Oral; Animals; Estradiol; Female; Liver; Ovariectomy; Prodrugs; Rats; Rats, Wistar | 2017 |
Secondary intracranial hypertension from testosterone therapy in a transgender patient.
Topics: Acetazolamide; Administration, Oral; Androgens; Blood Pressure; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid Pressure; Humans; Injections, Intramuscular; Intracranial Hypertension; Male; Papilledema; Testosterone; Testosterone Propionate; Tomography, X-Ray Computed; Transgender Persons; Visual Acuity; Young Adult | 2014 |